Vertex goes all-in on its effort to conquer cystic fibrosis – The Boston Globe, vertex pharma.#Vertex #pharma

Posted On May 8 2018 by

Vertex goes all-in on its effort to conquer cystic fibrosis Print View Comments Share on Twitter Share on Facebook Comment on this Scroll to top of page Now comes the hard part for Vertex Pharmaceuticals Inc. After launching two drugs aimed at nearly 40 percent of the 75,000 patients worldwide who suffer from cystic fibrosis, the biotech is mounting an assault on a range of mutations causing the obstructive lung disease in the remaining patients. Until the Vertex medicines hit the market, there was no treatment for the life-threatening condition, which causes serious lung infections that can result in respiratory …


Vertex Pharma’s 3-drug combo aids breathing in cystic fibrosis patients, vertex pharma.#Vertex #pharma

Posted On May 8 2018 by

Vertex Pharma s three-drug combinations improve breathing in some cystic fibrosis patients Vertex Pharmaceuticals said Tuesday that its three-drug cocktails improved a measure of lung function in patients with cystic fibrosis by 9.6 percentage points or more, surpassing Wall Street’s expectations and setting the company up to advance a medicine to treat thousands more patients with the disease. div > div.group > p:first-child”> In after-hours trading, Vertex shares surged more than 26 percent. The Boston-based biotech company is testing multiple combination regimens to find the best cocktail for a majority of patients with cystic fibrosis. Vertex has brought to market …


Flex Pharma, vertex pharma.#Vertex #pharma

Posted On May 8 2018 by

About Us President and Chief Executive Officer William K. McVicar, Ph.D., was appointed CEO in July 2017 after joining Flex Pharma in April 2017 as President of Research Development. Dr. McVicar brings to Flex Pharma approximately 30 years of clinical development experience. Prior to joining Flex Pharma, Dr. McVicar served as Executive Vice President of Pharmaceutical Development, Chief Scientific Officer, and President during his tenure at Inotek. As Vice President of Development Operations at Sepracor, he oversaw the development, FDA review, and approval of multiple NDAs and SNDAs, including BROVANA , XOPENEX MDI , and XOPENEX s pediatric approval, which …


VRTX stock quote – Vertex Pharmaceuticals Incorporated Common Stock price, vertex pharmaceuticals careers.#Vertex #pharmaceuticals #careers

Posted On Apr 18 2018 by

Vertex Pharmaceuticals Incorporated Common Stock Quote & Summary Data Stock Details COMPANY NEWS FUNDAMENTALS Edit Symbol List Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages. Don’t know the stock symbol? Use the Symbol Lookup tool. Alphabetize the sort order of my symbols Symbol Lookup Investing just got easier Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow. “Best Ask” is the lowest price currently being asked …


Vertex pharmaceuticals careers, vertex pharmaceuticals careers.#Vertex #pharmaceuticals #careers

Posted On Apr 18 2018 by

X-CHEM Main Menu homepage X-Chem and Gilead Announce Drug Discovery Collaboration WALTHAM, Mass. – November 28, 2017 – X-Chem, Inc. (X-Chem), a privately held biotechnology company applying its innovative drug discovery platform to the generation of novel small molecule therapeutics, announced today a drug discovery partnership with Gilead Sciences, Inc. (Gilead). Under the terms of the agreement, XChem will screen its proprietary DEXTM libraries, which contain [ ] Consortium of X-Chem, Harvard T.H. Chan School of Public Health and Other Leading Academic Institutions Wins Research Award from the Department of Defense X-Chem, Inc., a privately held biotechnology company with a …


VRTX stock quote – Vertex Pharmaceuticals Incorporated Common Stock price, vertex pharmaceuticals careers.#Vertex #pharmaceuticals #careers

Posted On Apr 18 2018 by

Vertex Pharmaceuticals Incorporated Common Stock Quote & Summary Data Stock Details COMPANY NEWS FUNDAMENTALS Edit Symbol List Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages. Don’t know the stock symbol? Use the Symbol Lookup tool. Alphabetize the sort order of my symbols Symbol Lookup Investing just got easier Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow. “Best Ask” is the lowest price currently being asked …


The Rise of Boston – s Seaport District, vertex pharmaceuticals careers.#Vertex #pharmaceuticals #careers

Posted On Apr 18 2018 by

The Rise of the Seaport By Matthew Reed Baker, Chris Vogel, and Patrick Doyle Over the past 150 years, the Seaport has undergone a series of transformations. It’s evolved from a muddy spot in Boston Harbor (much of it was covered by water until the late 1800s), to a thriving shipping area that in the early part of the 20th century received raw materials like wool and leather for local textile factories, to a decrepit no-man’s land of parking lots and abandoned warehouses in the mid-1900s, to its most recent iteration: a hotbed of construction and urban infill. Today, cranes …


Vertex Receives EU Approval for ORKAMBI – (lumacaftor, vertex pharmaceuticals inc.#Vertex #pharmaceuticals #inc

Posted On Apr 14 2018 by

Vertex Receives EU Approval for ORKAMBI (lumacaftor/ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis in People Ages 12 and Older with Two Copies of the F508del Mutation -In Europe, approximately 12,000 people with CF ages 12 and older have two copies of the F508del mutation- -Positive CHMP Opinion was received in September 2015 – -Country-by-country reimbursement process will now begin- LONDON –(BUSINESS WIRE)– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the European Commission has granted Marketing Authorization for ORKAMBI (lumacaftor/ivacaftor), the first medicine to treat the underlying cause of cystic fibrosis (CF) in people ages …


Flex Pharma, vertex pharma.#Vertex #pharma

Posted On Feb 26 2018 by

About Us President and Chief Executive Officer William K. McVicar, Ph.D., was appointed CEO in July 2017 after joining Flex Pharma in April 2017 as President of Research Development. Dr. McVicar brings to Flex Pharma approximately 30 years of clinical development experience. Prior to joining Flex Pharma, Dr. McVicar served as Executive Vice President of Pharmaceutical Development, Chief Scientific Officer, and President during his tenure at Inotek. As Vice President of Development Operations at Sepracor, he oversaw the development, FDA review, and approval of multiple NDAs and SNDAs, including BROVANA , XOPENEX MDI , and XOPENEX s pediatric approval, which …


VRTX stock quote – Vertex Pharmaceuticals Incorporated Common Stock price, vertex pharmaceuticals careers.#Vertex #pharmaceuticals #careers

Posted On Feb 14 2018 by

Vertex Pharmaceuticals Incorporated Common Stock Quote & Summary Data Stock Details COMPANY NEWS FUNDAMENTALS Edit Symbol List Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages. Don’t know the stock symbol? Use the Symbol Lookup tool. Alphabetize the sort order of my symbols Symbol Lookup Investing just got easier Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow. “Best Ask” is the lowest price currently being asked …